Read the latest from RareKids-CAN.
Investing in patient and family leadership is essential to advancing rare disease research, care, and treatment. Through RareKids-CAN's Patient and…
RareKids-CAN was pleased to sponsor two of our Clinical Trial Navigators, Cara Grobbecker and Faiza Khawaja to attend the American…
The Canadian National Mirror Group (NMG), led by RareKids-CAN, is helping ensure Canadian perspectives are represented in international efforts to…
Cell and gene therapies are rapidly transforming the pediatric rare disease treatment landscape and are offering new possibilities for conditions…
RareKids-CAN Nominated Principal Investigator and MICYRN Scientific Director Dr. Thierry Lacaze recently joined international leaders in a rare disease research,…
Canada is entering a new era in pediatric rare disease research, driven by advances in precision medicine and novel, innovative…
Clinical trials can play a critical role in improving access to treatments and advancing care for children living with rare…
RareKids-CAN’s Clinical Trial Navigators help strengthen pediatric rare disease clinical trial readiness across Canada by supporting study start-up, facilitating collaboration…
RareKids-CAN’s Clinical Trial Navigators help strengthen pediatric rare disease clinical trial capacity across Canada by serving as a local contact…
